Lanean...
Preclinical Evaluation of a Novel SIRT1 Modulator SRT1720 in Multiple Myeloma Cells
SIRT1 belongs to the silent information regulator 2 (Sir2) protein family of enzymes and functions as a NAD(+)-dependent class III histone deacetylase. Here, we examined the anti-multiple myeloma (MM) activity of a novel oral agent, SRT1720, which targets SIRT1. Treatment of MM cells with SRT1720 in...
Gorde:
| Argitaratua izan da: | Br J Haematol |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2011
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4391196/ https://ncbi.nlm.nih.gov/pubmed/21950728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2141.2011.08888.x |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|